These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 9626023)
21. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800 [TBL] [Abstract][Full Text] [Related]
24. Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments against the motion. Maetzel A Can J Gastroenterol; 2003 May; 17(5):335-8. PubMed ID: 12772009 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Brideau C; Van Staden C; Chan CC Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020 [TBL] [Abstract][Full Text] [Related]
26. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen. van Haeringen NJ; van Sorge AA; Carballosa Coré-Bodelier VM J Ocul Pharmacol Ther; 2000 Aug; 16(4):353-61. PubMed ID: 10977131 [TBL] [Abstract][Full Text] [Related]
27. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. Dallob A; Hawkey CJ; Greenberg H; Wight N; De Schepper P; Waldman S; Wong P; DeTora L; Gertz B; Agrawal N; Wagner J; Gottesdiener K J Clin Pharmacol; 2003 Jun; 43(6):573-85. PubMed ID: 12817520 [TBL] [Abstract][Full Text] [Related]
28. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922 [TBL] [Abstract][Full Text] [Related]
29. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575 [TBL] [Abstract][Full Text] [Related]
30. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006 [TBL] [Abstract][Full Text] [Related]
31. [New NSAIDS: COX-1, COX-2, what about them?]. Peretz A Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982 [TBL] [Abstract][Full Text] [Related]
32. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280 [TBL] [Abstract][Full Text] [Related]
33. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. Carabaza A; Cabré F; Rotllan E; Gómez M; Gutiérrez M; García ML; Mauleón D J Clin Pharmacol; 1996 Jun; 36(6):505-12. PubMed ID: 8809635 [TBL] [Abstract][Full Text] [Related]
34. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974 [TBL] [Abstract][Full Text] [Related]
35. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity. Shah AA; Murray FE; Fitzgerald DJ Rheumatology (Oxford); 1999 May; 38 Suppl 1():19-23. PubMed ID: 10369402 [TBL] [Abstract][Full Text] [Related]
36. The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts. Tobetto K; Yamamoto Y; Kataoka M; Ando T; Sugimoto K; Himeno M Jpn J Pharmacol; 1997 Dec; 75(4):371-9. PubMed ID: 9469643 [TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. Kato M; Nishida S; Kitasato H; Sakata N; Kawai S J Pharm Pharmacol; 2001 Dec; 53(12):1679-85. PubMed ID: 11804398 [TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Halter F; Tarnawski AS; Schmassmann A; Peskar BM Gut; 2001 Sep; 49(3):443-53. PubMed ID: 11511570 [TBL] [Abstract][Full Text] [Related]
39. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057 [TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Bjarnason I; Thjodleifsson B Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]